THE MERCK MANUAL, Sec. 14, Ch. 165, Neurologic Approach To The Patient
This Publication Is Searchable The Merck Manual of Diagnosis and Therapy--- Section 14. With intrinsic subarachnoid hemorrhage, the CSF remains uniformly bloody throughout collection, and if several hours have passed after ictus, RBC lysis produces xanthochromia, and crenated RBCs are seen microscopically. Increases of > 500 mg/dL are uncommon except in purulent meningitis,...
St. Jude Publications 2003 A - I (6/1/04)
In order for our site to display correctly you will need a newer version of your web browser. Benhayon D, Magdaleno S, Curran T.- Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. Hong Kong Journal of Paediatrics 8 (3): 170-183, 2003. Evans WE.- Pharmacogenomics: marshalling the human genome to individualise drug therapy.
author: St. Jude Children's Research Hospital
St. Jude Children's Research Hospital - Copyright 2003
- Related Topics Diagnostic Imaging Leukemia Treatment BONEII Protocol / Clinical Study - Sue C. Radiology 2002. (accepted) SL Hanna, SC Kaste, JJ Jenkins, K Hewan-Lowe, JV Spence, M Gupta*, D Monson, BD Fletcher. Accuracy of MR in predicting residual nonrhabdomyosarcoma soft tissue sarcoma (STS) following initial surgery. Athale UH*, Kaste SC, Razzouk B, Ribeiro RC.
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Departments Radiological Sciences Education DO Research Interests Pediatric oncologic imaging Diagnostic imaging of "late effects" of oncotherapy Orbital imaging Bone sequelae in childhood cancer survivors (bone mineral density; osteonecrosis) Selected Publications Haight AE*...
author: St. Jude Children's Research Hospital
St. Jude Children's Research Hospital - Copyright 2003
- Related Topics Diagnostic Imaging Leukemia Treatment BONEII Protocol / Clinical Study - Sue C. Radiology 2002. (accepted) SL Hanna, SC Kaste, JJ Jenkins, K Hewan-Lowe, JV Spence, M Gupta*, D Monson, BD Fletcher. Accuracy of MR in predicting residual nonrhabdomyosarcoma soft tissue sarcoma (STS) following initial surgery. Athale UH*, Kaste SC, Razzouk B, Ribeiro RC.
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Departments Radiological Sciences Education DO Research Interests Pediatric oncologic imaging Diagnostic imaging of "late effects" of oncotherapy Orbital imaging Bone sequelae in childhood cancer survivors (bone mineral density; osteonecrosis) Selected Publications Haight AE*...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty - Related Topics Diagnostic Imaging Leukemia Treatment BONEII Protocol / Clinical Study - Sue C. Relative nephrotoxicity of agents administered to pediatric allogeneic bone marrow transplant patients:-a model for predicting the effect of the contrast agent Iopamidol ...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Departments Radiological Sciences Education DO Research Interests Pediatric oncologic imaging Diagnostic imaging of "late effects" of oncotherapy Orbital imaging Bone sequelae in childhood cancer survivors (bone mineral density; osteonecrosis) Selected Publications Haight AE*...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Departments Radiological Sciences Education DO Research Interests Pediatric oncologic imaging Diagnostic imaging of "late effects" of oncotherapy Orbital imaging Bone sequelae in childhood cancer survivors (bone mineral density; osteonecrosis) Selected Publications Haight AE*...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Departments Radiological Sciences Education DO Research Interests Pediatric oncologic imaging Diagnostic imaging of "late effects" of oncotherapy Orbital imaging Bone sequelae in childhood cancer survivors (bone mineral density; osteonecrosis) Selected Publications Haight AE*...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Departments Radiological Sciences Education DO Research Interests Pediatric oncologic imaging Diagnostic imaging of "late effects" of oncotherapy Orbital imaging Bone sequelae in childhood cancer survivors (bone mineral density; osteonecrosis) Selected Publications Haight AE*...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty Departments Radiological Sciences Education DO Research Interests Pediatric oncologic imaging Diagnostic imaging of "late effects" of oncotherapy Orbital imaging Bone sequelae in childhood cancer survivors (bone mineral density; osteonecrosis) Selected Publications Haight AE*...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty - Related Topics Diagnostic Imaging Leukemia Treatment BONEII Protocol / Clinical Study - Sue C. Relative nephrotoxicity of agents administered to pediatric allogeneic bone marrow transplant patients:-a model for predicting the effect of the contrast agent Iopamidol ...
author: St. Jude Children's Research Hospital
Sue C. Kaste, DO
In order for our site to display correctly you will need a newer version of your web browser. Jude Faculty - Related Topics Diagnostic Imaging Leukemia Treatment BONEII Protocol / Clinical Study - Sue C. Relative nephrotoxicity of agents administered to pediatric allogeneic bone marrow transplant patients:-a model for predicting the effect of the contrast agent Iopamidol ...
author: St. Jude Children's Research Hospital
http://www.biosis.org/ts/media/cdjournals/gazettenews/2001/CPG_News_0150.pdf
US applications (pre-grant publications) were published on schedule on December 13 th , but there were problems with the USPTOs website load. The leuporelin issue is not entirely straightforward, since it is Takeda and TAP (Takeda/Abbott) who have commercialized Leuplin. These include an oral perfluorocarbon microbubble product, Imagent GI, now discontinued in the US, and...
1996 and Older - New Drug Application (NDA)
New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office 20195/S-002 5/20/96 8/2/99 Fragmin/dalteparin sodium Injection [1.5 MB] Pharmacia and Upjohn 020287/S005 9/24/1996 2/4/1998 Heptolite, Kit for the Preparation of Technetium Tc 99m Disofenin Merck 18467/ S-13 & S-14 12/29/1993 8/5...
http://www.fda.gov/cder/orange/appendix_a.txt
ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
THE MERCK MANUAL, Sec. 14, Ch. 165, Neurologic Approach To The Patient
This Publication Is Searchable The Merck Manual of Diagnosis and Therapy--- Section 14 With intrinsic subarachnoid hemorrhage, the CSF remains uniformly bloody throughout collection, and if several hours have passed after ictus, RBC lysis produces xanthochromia, and crenated RBCs are seen microscopically Increases of > 500 mg/dL are uncommon except in purulent meningitis,...
Maximum Recommended Therapeutic Dose (MRTD) Database
Maximum Recommended Therapeutic Dose (MRTD) Database (1,235 pharmaceuticals) A -- B- - C -- D -- E -- F-G -- H-K -- L -- M -- N -- O -- P -- Q-R -- S -- T -- U-Z MRTD--- (mg/kg--- bw/day) -- Generic Chemical Name Chemical Structure (SMILES Code) 3.00000-- Acemetacin C1=C(OC)C=C3C(=C1)N(C(=O)C2=CC=C(Cl)C=C2)C(C)=C3CC(=O)OCC(O)=O 0.20000-- Acenocoumarol C1=CC=C3C(=C1)OC(=O)C(C(CC(C)=O...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
"SOTALOL HCL, MANUFACTURED IN MILANO, ITALY" 12274 13-Dec-96 SANKYO CO LTD "CS-834 DRUG SUBSTANCE, MANUFACTURED IN KANAGAWA, JAPAN" 12276 13-Dec-96 SANKYO CO LTD "CS-834 DRUG PRODUCT, MANUFACTURED IN TOKYO, JAPAN" 12277 16-Dec-96 PHARMA WALDHOF GMBH AND CO "5-BROMO-2'-DEOXYURIDINE, MANUFACTURED IN MANNHEIM, GERMANY" 12279 12-Dec-96 UNION QUIMICO FARMACEUTICA SA "PENTAACETYLIOPAMIDOL,...
OGD Suitability Tracking Reports (Sorted by Petition Number) as of 1/5/2004
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -OGD Suitability Tracking Report (Sorted by Petition Number) as of 1/5/2004 Drug/Strength Petition No/Firm Dosage Form Status Status Date ACETAMINOPHEN 300 MG HYDROCODONE BITARTRATE 5 MG, 7.5 MG, 10 MG - 03P-0436/CP1 ANABOLIC LABORATORIES - - - 9/22/2003- TRIPELENNAMINE HYDROCHLORIDE 25 MG/5...
OGD Suitability Tracking Reports (Sorted by Drug Name) as of 1/5/2004
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -OGD Suitability Tracking Report (Sorted by Drug Name) as of 1/5/2004 Drug/Strength Petition No/Firm Dosage Form Status Status Date ACETAMINOPHEN 200MG;200MG; 200MG HYDROCODONE BITARTRATE 5MG;7.5MG;10MG - 02P-0004/CP1 SHOTWELL AND CARR, INC - TABLET; ORAL Approved 2/28/2003- CALCITONIN...
Reference Listed Drug Labeling Approved in June 2002
Food and Drug Administration Center for Drug Evaluation and Research Office of Generic Drugs Search Reference Listed Drug Labeling and Efficacy Supplements Approved in July 2002 Click on appropriate hyperlink below to view available source document in PDF format Approval Date Product Name Source Documents Active Ingredient(s)/Dosage Form Document ID No Jul 2 FORTOVASE...
author: USERNAME
Reference Listed Drug Labeling Approved in June 2002
Approval Date Product Name - - Active Ingredient(s) Dosage Form NDA No Supp No -- TRIZIVIR -- letter label abacavir sulfate, lamivudine, zidovudine tablets 21-205 SLR 004 -Jun 4 CAFERGOT letter label ergotamine tartrate and caffeine suppositories 09-000 SLR 022 -- M.V.I.-12 letter - multi-vitamins for infusion injection 08-809 SLR 046 --- PEPCID injection letter label famotidine...
author: USERNAME
Prescription and Over-the-Counter Drug Product List: 8/2003
4 >D> AA + ORTHO MCNEIL PHARM 300MG;60MG N85055 004 AUG DISC >A> @ 300MG;60MG N85055 004 AUG DISC ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA + MALLINCKRODT 500MG/15ML;10MG/15ML N40508 001 AUG 29, 2003 AUG NEWA >D> MIKART 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG CTEC >A> AA 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG...
author: AUTHOR